Company news

Arecor Therapeutics PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Patents for concentrated ultra-rapid insulins

October 15, 2026

Holding(s) in Company

October 13, 2026

Holding(s) in Company

October 13, 2026

Half Year Results Investor Presentation

October 8, 2026

Holding(s) in Company

October 8, 2026

Result of Retail Offer

October 7, 2026

Holding(s) in Company

October 7, 2026

Retail Offer to raise up to £130,000

September 30, 2026

Results of Placing

September 30, 2026

Close of Accelerated Bookbuild to New Orders

September 30, 2026

Proposed Fundraising to raise up to £5.13 million

September 30, 2026

Interim results for the six months to 30 June 2026

September 30, 2026

AT278 data published in peer-reviewed journal

August 13, 2026

Grant of options and PDMR dealing

May 21, 2026

Upcoming conference attendance

May 18, 2026

Posting of Annual Report and Notice of AGMm

April 28, 2026

Final Results

April 13, 2026

Notice of FY25 Results

March 30, 2026

Ligand Pharmaceuticals Milestone Payment

March 26, 2026

Arecor to present at Oppenheimer conference

March 9, 2026

2025 Business Update

February 9, 2026

Fireside Panel Discussion on Diabetes sector

January 6, 2026

Arecor and Sequel Med Tech to host fireside panel

December 9, 2025

Holding(s) in Company

November 17, 2025

Enhanced IP Coverage: AT278 & Oral Peptide Program

November 4, 2025

Directorate Changes

September 29, 2025

Arecor announces Co-development Agreement with US Insulin Pump Device Company for AT278 & Sale of Royalty Rights and Technology Access Fees for AT220 and AT292

September 25, 2025

Interim results for the six months to 30 June 2025

September 25, 2025

Co-Development Agreement & Monetisation Deal

September 25, 2025

Notice of Interim Results

September 24, 2025

Positive FDA Feedback on Phase 2 Study Design

September 4, 2025

Change of Auditor

August 8, 2025

Arecor Establishes New Scientific Advisory Board

July 14, 2025

Grant of Options and PDMR Dealing

June 4, 2025

Result of AGM

June 2, 2025

Non-Executive Director Board Change

June 2, 2025

Director/PDMR Dealing

May 21, 2025

Arecor Partnership with Skye Bioscience

May 19, 2025

Director Dealing

May 14, 2025

Arecor sells rights to non-Ogluo® products

May 8, 2025

Posting of 2024 Annual Report and Notice of AGM

May 6, 2025

Arecor to present on Investor Meet Company

April 24, 2025

Final results for 2024

April 22, 2025

Notice of Results

April 10, 2025

Collaboration with global pharmaceutical partner

March 26, 2025

Arecor partnership with biopharmaceutical company

March 12, 2025

Arecor Full Year 2024 Trading Update

February 3, 2025

Orderly Cessation of Tetris Pharma Operations

January 10, 2025

Change of Nominated Advisor and Joint Broker

January 9, 2025

Arecor Signs Exclusive Licensing Agreement

December 30, 2024

Older news releases →

Calls

The 5 newest of 9 calls. Every call is listed under its year.

Decks

The 5 newest of 11 decks. Every deck is listed under its year.